<?xml version="1.0" encoding="UTF-8"?>
<ref id="B41-antioxidants-09-01099">
 <label>41.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Schröter</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Neugart</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Schreiner</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Grune</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Rohn</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Ott</surname>
    <given-names>C.</given-names>
   </name>
  </person-group>
  <article-title>Amaranth’s 2-caffeoylisocitric acid—An anti-inflammatory caffeic acid derivative that impairs NF-κB signaling in LPS-challenged RAW 264.7 macrophages</article-title>
  <source>Nutrients</source>
  <year>2019</year>
  <volume>11</volume>
  <elocation-id>571</elocation-id>
  <pub-id pub-id-type="doi">10.3390/nu11030571</pub-id>
  <?supplied-pmid 30866427?>
  <pub-id pub-id-type="pmid">30866427</pub-id>
 </element-citation>
</ref>
